Metformin enhances the differentiation and mineralization of osteoblastic MC3T3-E1 cells via AMP kinase activation as well as eNOS and BMP-2 expression
- 24 October 2008
- journal article
- research article
- Published by Elsevier BV in Biochemical and Biophysical Research Communications
- Vol. 375 (3), 414-419
- https://doi.org/10.1016/j.bbrc.2008.08.034
Abstract
No abstract availableKeywords
This publication has 29 references indexed in Scilit:
- Adiponectin and AMP kinase activator stimulate proliferation, differentiation, and mineralization of osteoblastic MC3T3-E1 cellsBMC Cell Biology, 2007
- AMP-activated protein kinase signaling in metabolic regulationJCI Insight, 2006
- Nontraumatic Fracture Risk With Diabetes Mellitus and Impaired Fasting Glucose in Older White and Black AdultsArchives of Internal Medicine, 2005
- AMP-activated protein kinase: Ancient energy gauge provides clues to modern understanding of metabolismCell Metabolism, 2005
- Analysis of Relative Gene Expression Data Using Real-Time Quantitative PCR and the 2−ΔΔCT MethodMethods, 2001
- Role of AMP-activated protein kinase in mechanism of metformin actionJCI Insight, 2001
- Nitric oxide and boneImmunology, 2001
- AMP‐activated protein kinase phosphorylation of endothelial NO synthaseFEBS Letters, 1999
- In vitro differentiation and calcification in a new clonal osteogenic cell line derived from newborn mouse calvaria.The Journal of cell biology, 1983
- Modulation of 3-hydroxy-3-methylglutaryl coenzyme A reductase activity with cAMP and with protein fractions of rat liver cytosolBiochemical and Biophysical Research Communications, 1973